Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN: Safety Overview

Metric HUMAN C1-ESTERASE INHIBITOR HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
Total FAERS Reports 14,344 4,369
Deaths Reported 1,403 446
Death Rate 9.8% 10.2%
Hospitalizations 3,966 1,044
Average Patient Age 42.7 yrs 50.8 yrs
% Female Patients 79.1% 71.6%
Manufacturer Takeda Pharmaceuticals America, Inc. N/A